Showing posts with the label Medtronic

Medtronic Expands ENT Portfolio with FDA Clearance of NIM Vital™ Next Generation Intraoperative Nerve Monitoring System and Acquisiton of Ai Biomed Corp.

Medtronic announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital™ nerve monitoring system, which enables physicians to identify, confirm, and monitor ner…

Medtronic Venous Stent Receives U.S. FDA Approval to Treat Venous Outflow Obstruction

Medtronic announced it has received U.S. Food and Drug Administration (FDA) approval for the Abre™ venous self-expanding stent system. This device is indicated for use in the iliofemoral veins in pa…

Nine-Month Results from Medtronic IN.PACT BTK Study Presented in Late-Breaking Clinical Trial Sessions at TCT Connect Annual Meeting

Medtronic announced the first-ever results from the IN.PACT BTK Study, a feasibility study assessing the safety and effectiveness of the IN.PACT 0.014 drug-coated balloon (DCB) in critical limb ische…

Medtronic Donates Nearly $1 Million in Personal Protective Equipment to International Medical Corps for COVID-19 Response Efforts

Medtronic donated nearly $1 million worth of personal protective equipment (PPE) to relief organization International Medical Corps to support its ongoing COVID-19 response efforts in the continental…

Medtronic Announces Adaptix™ Interbody System, the First Navigated Titanium Cage with Titan nanoLOCK™ Surface Technology

Medtronic announced the U.S. launch of Adaptix™ Interbody System, the first navigated titanium implant with Titan nanoLOCK™ Surface Technology, a proprietary blend of surface textures on the macro, m…

Medtronic Announces First Patient Implanted in ELITE Study of InterStim™ Micro

Medtronic announced the first patient was implanted in its ELITE study of the InterStim™ Micro system — the only study of a rechargeable sacral neurostimulation (SNS) system to include all SNS indica…
Subscribe Our Newsletter